NICARDIPINE HYDROCHLORIDE

NICARDIPINE HYDROCHLORIDE was reported 2241 times

NICARDIPINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URETERIC COMPRESSION 14 0.1842
1 LABOUR ONSET DELAYED 2 0.1818
2 ALCOHOLIC COMA 2 0.1176
3 NEUTROPENIA NEONATAL 26 0.1161
4 ALEXITHYMIA 5 0.1000
5 ANEURYSM ARTERIOVENOUS 1 0.0769
6 ACQUIRED ANTITHROMBIN III DEFICIENCY 1 0.0714
7 CRANIOPLASTY 3 0.0600
8 SUPERIMPOSED PRE-ECLAMPSIA 2 0.0571
9 FOETAL DISORDER 41 0.0490
10 ANTI-PLATELET FACTOR 4 ANTIBODY POSITIVE 1 0.0435
11 XANTHELASMA 4 0.0348
12 ODONTOGENIC CYST 2 0.0323
13 HYPERPLASIA ADRENAL 2 0.0317
14 BLOOD LACTIC ACID 4 0.0310
15 HEMIVERTEBRA 5 0.0296
16 WRONG PATIENT 13 0.0259
17 ANASTOMOTIC FISTULA 2 0.0253
18 HEPARIN RESISTANCE 3 0.0246
19 BURKHOLDERIA TEST POSITIVE 3 0.0242
20 TERM BIRTH 3 0.0217
21 ADRENAL CARCINOMA 1 0.0213
22 DIABETIC KETOSIS 8 0.0211
23 SICCA SYNDROME 4 0.0207
24 LEFT-TO-RIGHT CARDIAC SHUNT 6 0.0203
25 BRONCHOPULMONARY DISEASE 2 0.0202
26 FOETAL MOVEMENTS DECREASED 2 0.0196
27 AV DISSOCIATION 1 0.0192
28 BILIARY ISCHAEMIA 1 0.0189
29 CONGENITAL CHOROID PLEXUS CYST 5 0.0164
30 FOETAL HEART RATE DISORDER 3 0.0155
31 URINE SODIUM DECREASED 2 0.0154
32 VASCULAR RESISTANCE SYSTEMIC DECREASED 2 0.0149
33 FOETAL ARRHYTHMIA 4 0.0149
34 PYELOCALIECTASIS 14 0.0146
35 MESENTERIC ARTERIAL OCCLUSION 2 0.0142
36 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 3 0.0139
37 CANDIDURIA 2 0.0135
38 DEVICE COMPUTER ISSUE 4 0.0134
39 VERTEBRAL ARTERY STENOSIS 2 0.0129
40 HAEMATOMA MUSCLE 15 0.0125
41 PHLEBOLITH 2 0.0118
42 NEONATAL RESPIRATORY DISTRESS 11 0.0117
43 ALPHA HYDROXYBUTYRATE DEHYDROGENASE INCREASED 1 0.0116
44 BRAIN STEM ISCHAEMIA 2 0.0112
45 ATRIOVENTRICULAR SEPTAL DEFECT 5 0.0106
46 AMNIORRHOEA 2 0.0105
47 ANAEMIA NEONATAL 5 0.0104
48 HAEMORRHAGIC CEREBRAL INFARCTION 7 0.0100
49 VIRAL HAEMORRHAGIC CYSTITIS 7 0.0098
50 MATERNAL CONDITION AFFECTING FOETUS 2 0.0090
51 BENIGN SALIVARY GLAND NEOPLASM 1 0.0086
52 ANTICOAGULATION DRUG LEVEL DECREASED 1 0.0083
53 WEANING FAILURE 3 0.0082
54 NEUROMUSCULAR BLOCK PROLONGED 3 0.0081
55 LIVER CARCINOMA RUPTURED 2 0.0079
56 CRYSTALLURIA 4 0.0074
57 VENTILATION PERFUSION MISMATCH 2 0.0071
58 PUTAMEN HAEMORRHAGE 2 0.0070
59 FIBRIN DEGRADATION PRODUCTS INCREASED 2 0.0068
60 RETINOPATHY HYPERTENSIVE 2 0.0066
61 FOETAL DISTRESS SYNDROME 14 0.0066
62 ASPERGILLUS TEST POSITIVE 2 0.0065
63 BRONCHOPULMONARY DYSPLASIA 5 0.0062
64 APGAR SCORE LOW 8 0.0062
65 RED BLOOD CELL SCHISTOCYTES PRESENT 2 0.0062
66 CNS VENTRICULITIS 2 0.0061
67 BASILAR ARTERY OCCLUSION 1 0.0060
68 BACTERIAL PYELONEPHRITIS 2 0.0060
69 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
70 DIABETIC METABOLIC DECOMPENSATION 8 0.0058
71 MYOGLOBINURIA 3 0.0056
72 LOW BIRTH WEIGHT BABY 44 0.0055
73 NEONATAL HYPOTENSION 2 0.0054
74 THROMBOCYTHAEMIA 3 0.0054
75 CYSTITIS VIRAL 2 0.0052
76 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
77 VITAMIN K DEFICIENCY 2 0.0050
78 NECROTISING ENTEROCOLITIS NEONATAL 2 0.0049
79 CANDIDA TEST POSITIVE 2 0.0048
80 BACTERIAL DIARRHOEA 1 0.0047
81 GESTATIONAL HYPERTENSION 6 0.0046
82 THALAMUS HAEMORRHAGE 4 0.0046
83 HEPATIC CYTOLYSIS 58 0.0045
84 EMBOLIC CEREBRAL INFARCTION 3 0.0045
85 POSTPARTUM HAEMORRHAGE 6 0.0045
86 INTESTINAL INFARCTION 4 0.0044
87 THROMBOCYTOPENIC PURPURA 6 0.0044
88 INTRA-UTERINE DEATH 7 0.0044
89 ACUTE MOTOR-SENSORY AXONAL NEUROPATHY 1 0.0043
90 ACUTE PULMONARY OEDEMA 24 0.0043
91 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0042
92 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
93 DYSLALIA 3 0.0041
94 CLONIC CONVULSION 3 0.0041
95 CEREBRAL ARTERY STENOSIS 2 0.0041
96 CEREBRAL VASOCONSTRICTION 3 0.0041
97 ACETONAEMIA 1 0.0040
98 SPLENIC VEIN THROMBOSIS 2 0.0039
99 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
100 FOETAL GROWTH RETARDATION 3 0.0038
101 PRODUCT INEFFECTIVE 3 0.0038
102 ENDOCARDITIS BACTERIAL 3 0.0038
103 JAUNDICE NEONATAL 7 0.0037
104 INTERTRIGO 2 0.0037
105 ANTITHROMBIN III DECREASED 1 0.0037
106 INTRACRANIAL HAEMATOMA 2 0.0036
107 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 27 0.0035
108 NECROTISING MYOSITIS 3 0.0035
109 HYPERTHERMIA MALIGNANT 5 0.0034
110 HAEMORRHAGIC TRANSFORMATION STROKE 5 0.0033
111 PREMATURE BABY 98 0.0033
112 PRE-ECLAMPSIA 15 0.0032
113 FOETAL GROWTH RESTRICTION 19 0.0031
114 EMBOLIC STROKE 11 0.0031
115 RED BLOOD CELLS URINE POSITIVE 3 0.0031
116 APPLICATION SITE OEDEMA 1 0.0031
117 EPIDERMAL NECROSIS 3 0.0031
118 PREMATURE DELIVERY 49 0.0031
119 LICHENOID KERATOSIS 7 0.0031
120 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
121 POTENTIATING DRUG INTERACTION 10 0.0030
122 CYTOKINE STORM 2 0.0029
123 SOFT TISSUE NECROSIS 2 0.0029
124 HYPOSPADIAS 6 0.0029
125 SJS-TEN OVERLAP 2 0.0028
126 MALARIA 2 0.0028
127 CEREBELLAR HAEMORRHAGE 4 0.0028
128 BIPOLAR II DISORDER 1 0.0028
129 PATENT DUCTUS ARTERIOSUS 11 0.0028
130 CAESAREAN SECTION 31 0.0027
131 EOSINOPHILIA 46 0.0026
132 ALKALOSIS 1 0.0026
133 ESCHERICHIA BACTERAEMIA 6 0.0025
134 PNEUMONIA STAPHYLOCOCCAL 5 0.0025
135 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 2 0.0025
136 ELECTROMECHANICAL DISSOCIATION 2 0.0025
137 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 3 0.0025
138 LYMPHOCYTE STIMULATION TEST POSITIVE 2 0.0025
139 LYMPHANGITIS 2 0.0025
140 KETONURIA 2 0.0025
141 ARTERY DISSECTION 1 0.0024
142 INTRA-ABDOMINAL HAEMATOMA 3 0.0024
143 AORTIC DISSECTION 10 0.0024
144 CSF PROTEIN INCREASED 2 0.0024
145 TWIN PREGNANCY 2 0.0024
146 APPARENT LIFE THREATENING EVENT 1 0.0024
147 BRAIN HERNIATION 7 0.0023
148 ANAL SPHINCTER ATONY 1 0.0023
149 FIXED ERUPTION 4 0.0023
150 LEFT VENTRICULAR FAILURE 8 0.0023
151 CARDIAC OUTPUT DECREASED 2 0.0023
152 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 4 0.0023
153 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
154 THERAPEUTIC PRODUCT CROSS-REACTIVITY 2 0.0022
155 CANDIDA SEPSIS 2 0.0022
156 OFF LABEL USE OF DEVICE 3 0.0022
157 ANAPHYLACTOID REACTION 9 0.0022
158 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0022
159 RASH MORBILLIFORM 6 0.0022
160 RASH MACULO-PAPULAR 48 0.0022
161 VASCULAR PURPURA 3 0.0021
162 PRERENAL FAILURE 3 0.0021
163 PROTHROMBIN LEVEL DECREASED 2 0.0021
164 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 3 0.0021
165 PREMATURE LABOUR 12 0.0021
166 INTERVERTEBRAL DISCITIS 4 0.0021
167 INTRACRANIAL MASS 2 0.0021
168 BRAIN STEM HAEMORRHAGE 2 0.0021
169 CYTOLYTIC HEPATITIS 7 0.0021
170 PARTIAL SEIZURES 11 0.0021
171 OLIGOHYDRAMNIOS 7 0.0021
172 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
173 BLAST CELLS PRESENT 1 0.0021
174 BLOOD BICARBONATE INCREASED 1 0.0021
175 RASH PUSTULAR 15 0.0021
176 CROSS SENSITIVITY REACTION 2 0.0021
177 AMNESTIC DISORDER 1 0.0021
178 PSYCHIATRIC DECOMPENSATION 4 0.0020
179 OCCULT BLOOD POSITIVE 4 0.0020
180 MATERNAL EXPOSURE DURING DELIVERY 2 0.0020
181 PHLEBITIS 10 0.0020
182 THROMBOTIC MICROANGIOPATHY 19 0.0019
183 HYPERURICAEMIA 8 0.0019
184 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
185 BLOOD ALBUMIN ABNORMAL 1 0.0019
186 ELECTROENCEPHALOGRAM ABNORMAL 6 0.0019
187 ENTEROCOCCAL BACTERAEMIA 2 0.0019
188 FEBRILE BONE MARROW APLASIA 8 0.0019
189 HYPERLACTACIDAEMIA 5 0.0019
190 PRODUCT SELECTION ERROR 2 0.0018
191 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
192 TINEA INFECTION 2 0.0018
193 POISONING DELIBERATE 17 0.0018
194 KLEBSIELLA SEPSIS 2 0.0018
195 APNOEIC ATTACK 1 0.0018
196 ANURIA 15 0.0017
197 CARBON DIOXIDE DECREASED 2 0.0017
198 ISCHAEMIC CEREBRAL INFARCTION 2 0.0017
199 RECTAL ULCER 2 0.0017
200 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
201 CEREBRAL VENOUS THROMBOSIS 3 0.0017
202 CEREBRAL ARTERY EMBOLISM 2 0.0016
203 RENAL ATROPHY 2 0.0016
204 ARTERITIS 1 0.0016
205 NECROTISING COLITIS 2 0.0016
206 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
207 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0016
208 HAEMOLYTIC ANAEMIA 14 0.0016
209 PNEUMONIA ASPIRATION 39 0.0016
210 TRAUMATIC LUNG INJURY 3 0.0016
211 ACUTE GRAFT VERSUS HOST DISEASE 7 0.0015
212 DRUG EXPOSURE DURING PREGNANCY 52 0.0015
213 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 3 0.0015
214 CEREBRAL INFARCTION 37 0.0015
215 EXTRADURAL HAEMATOMA 2 0.0015
216 ALCOHOL POISONING 4 0.0015
217 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
218 ABSCESS NECK 1 0.0015
219 INTESTINAL ISCHAEMIA 8 0.0015
220 AKINESIA 3 0.0014
221 RHONCHI 2 0.0014
222 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
223 DILATATION VENTRICULAR 3 0.0014
224 PROTHROMBIN TIME SHORTENED 2 0.0014
225 PERIPHERAL ARTERY OCCLUSION 2 0.0014
226 HEART DISEASE CONGENITAL 5 0.0014
227 ENTERITIS 9 0.0014
228 ANAEMIA MACROCYTIC 3 0.0014
229 TOXIC SKIN ERUPTION 14 0.0014
230 CHRONIC GRAFT VERSUS HOST DISEASE 5 0.0014
231 DERMATITIS BULLOUS 10 0.0014
232 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
233 APALLIC SYNDROME 1 0.0014
234 WRONG PATIENT RECEIVED PRODUCT 4 0.0014
235 PURPURA 12 0.0014
236 AMYLASE INCREASED 5 0.0014
237 CYTOMEGALOVIRUS VIRAEMIA 6 0.0013
238 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
239 ILEUS PARALYTIC 6 0.0013
240 ACUTE CORONARY SYNDROME 11 0.0013
241 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0013
242 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
243 COAGULATION TIME PROLONGED 2 0.0013
244 SINUS ARREST 2 0.0013
245 FUNGAEMIA 2 0.0013
246 BLOOD FIBRINOGEN INCREASED 1 0.0013
247 NEONATAL DISORDER 2 0.0013
248 ORTHOPNOEA 4 0.0013
249 CEREBRAL ATROPHY 5 0.0013
250 TOXIC EPIDERMAL NECROLYSIS 19 0.0012
251 CHOLESTASIS 24 0.0012
252 CREATININE RENAL CLEARANCE DECREASED 5 0.0012
253 SKIN EROSION 4 0.0012
254 HYPOGLYCAEMIA NEONATAL 2 0.0012
255 CHOLECYSTITIS ACUTE 7 0.0012
256 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
257 RESPIRATORY ALKALOSIS 2 0.0012
258 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
259 HYPOVENTILATION 4 0.0012
260 VASOPLEGIA SYNDROME 2 0.0012
261 BRADYARRHYTHMIA 2 0.0012
262 QUADRIPARESIS 2 0.0012
263 SYSTEMIC CANDIDA 3 0.0012
264 CEREBRAL HAEMATOMA 4 0.0012
265 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
266 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
267 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
268 BLOOD ALBUMIN DECREASED 9 0.0011
269 JUGULAR VEIN THROMBOSIS 2 0.0011
270 INDURATION 2 0.0011
271 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
272 CAROTID ARTERY OCCLUSION 4 0.0011
273 SUBDURAL HAEMORRHAGE 3 0.0011
274 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
275 IMMUNE THROMBOCYTOPENIA 5 0.0011
276 ANEURYSM RUPTURED 1 0.0011
277 THROMBOCYTOSIS 4 0.0011
278 ISCHAEMIA 5 0.0011
279 HEMIPLEGIA 9 0.0011
280 PUPILLARY REFLEX IMPAIRED 2 0.0011
281 SUBARACHNOID HAEMORRHAGE 11 0.0011
282 MATERNAL EXPOSURE TIMING UNSPECIFIED 4 0.0011
283 HEPATIC NECROSIS 4 0.0011
284 HYPOPROTEINAEMIA 2 0.0011
285 CARDIAC TAMPONADE 5 0.0011
286 ARNOLD-CHIARI MALFORMATION 1 0.0010
287 VENTRICULAR SEPTAL DEFECT 6 0.0010
288 HYPONATRAEMIA 59 0.0010
289 ARTERIAL DISORDER 2 0.0010
290 ACTINOMYCOSIS 1 0.0010
291 ADENOVIRUS INFECTION 3 0.0010
292 RALES 6 0.0010
293 STAPHYLOCOCCAL SEPSIS 5 0.0010
294 HEPATITIS FULMINANT 3 0.0010
295 BLOOD CULTURE POSITIVE 3 0.0010
296 ACQUIRED HAEMOPHILIA 1 0.0010
297 CIRCULATORY COLLAPSE 17 0.0010
298 MIXED LIVER INJURY 3 0.0010
299 HEPATIC FUNCTION ABNORMAL 37 0.0010
300 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
301 RESPIRATORY DISTRESS 27 0.0010
302 CEREBRAL HAEMORRHAGE 35 0.0010
303 GOITRE 4 0.0010
304 MATERNAL EXPOSURE DURING PREGNANCY 87 0.0010
305 BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0010
306 HYPERPARATHYROIDISM 2 0.0010
307 ABSCESS JAW 1 0.0010
308 MICROCYTIC ANAEMIA 2 0.0010
309 SUBILEUS 2 0.0010
310 CATATONIA 5 0.0010
311 EOSINOPHILIC PNEUMONIA 3 0.0010
312 HALLUCINATIONS, MIXED 4 0.0010
313 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
314 STUPOR 3 0.0009
315 PERIODONTITIS 2 0.0009
316 HYDROCEPHALUS 5 0.0009
317 FOETAL EXPOSURE DURING PREGNANCY 74 0.0009
318 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
319 RETROPERITONEAL HAEMATOMA 2 0.0009
320 GASTRIC ULCER HAEMORRHAGE 5 0.0009
321 AORTIC DILATATION 1 0.0009
322 HYPOALBUMINAEMIA 7 0.0009
323 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
324 CLOSTRIDIAL INFECTION 3 0.0009
325 SUSPECTED OFF LABEL USE 4 0.0009
326 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
327 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
328 KOUNIS SYNDROME 2 0.0009
329 UROSEPSIS 8 0.0009
330 NEUROLOGICAL DECOMPENSATION 2 0.0009
331 ACUTE PRERENAL FAILURE 1 0.0009
332 SHOCK HAEMORRHAGIC 7 0.0009
333 BILIRUBIN CONJUGATED INCREASED 2 0.0009
334 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22 0.0009
335 PANCREATITIS ACUTE 19 0.0008
336 COLITIS MICROSCOPIC 4 0.0008
337 FIBRIN D DIMER INCREASED 3 0.0008
338 HAEMORRHAGIC DIATHESIS 3 0.0008
339 BILE DUCT CANCER 1 0.0008
340 GRAFT VERSUS HOST DISEASE 6 0.0008
341 KIDNEY TRANSPLANT REJECTION 4 0.0008
342 HEPATITIS CHOLESTATIC 5 0.0008
343 BLEEDING TIME PROLONGED 1 0.0008
344 HYPOKALAEMIA 38 0.0008
345 BLOOD PHOSPHORUS DECREASED 3 0.0008
346 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
347 RHABDOMYOLYSIS 34 0.0008
348 HEPARIN-INDUCED THROMBOCYTOPENIA 4 0.0008
349 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
350 MULTI-ORGAN FAILURE 14 0.0008
351 LEUKOENCEPHALOPATHY 3 0.0008
352 ORTHOSTATIC HYPOTENSION 14 0.0008
353 PROTEIN URINE PRESENT 4 0.0008
354 PERSECUTORY DELUSION 2 0.0008
355 TACHYARRHYTHMIA 2 0.0008
356 DERMATITIS EXFOLIATIVE 4 0.0008
357 VENOOCCLUSIVE DISEASE 2 0.0008
358 PROTEIN TOTAL DECREASED 3 0.0008
359 PRODUCT ADMINISTRATION ERROR 16 0.0008
360 ACUTE KIDNEY INJURY 121 0.0008
361 HYPOMAGNESAEMIA 11 0.0008
362 TOXIC ENCEPHALOPATHY 4 0.0008
363 TROPONIN INCREASED 6 0.0008
364 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
365 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
366 NEUTROPHIL COUNT INCREASED 8 0.0008
367 ADENOCARCINOMA PANCREAS 1 0.0008
368 CEREBRAL ISCHAEMIA 4 0.0008
369 BLOOD UREA INCREASED 13 0.0008
370 FOETAL DEATH 4 0.0008
371 HYPERKALAEMIA 27 0.0008
372 HEPATITIS ACUTE 5 0.0008
373 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
374 ASPERGILLOSIS 1 0.0008
375 RADICULOPATHY 2 0.0008
376 BRADYCARDIA 40 0.0008
377 AGRANULOCYTOSIS 14 0.0008
378 YAWNING 2 0.0007
379 ARTERIOSPASM CORONARY 3 0.0007
380 WHITE BLOOD CELL DISORDER 2 0.0007
381 COMPRESSION FRACTURE 4 0.0007
382 ADRENAL INSUFFICIENCY 9 0.0007
383 POSTOPERATIVE WOUND INFECTION 5 0.0007
384 WRONG PRODUCT ADMINISTERED 5 0.0007
385 EXTRAVASATION 3 0.0007
386 RED BLOOD CELL COUNT INCREASED 2 0.0007
387 EPILEPSY 22 0.0007
388 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
389 SERUM SICKNESS 2 0.0007
390 ATRIAL SEPTAL DEFECT 6 0.0007
391 LUNG CONSOLIDATION 2 0.0007
392 ANAL HAEMORRHAGE 2 0.0007
393 ENDOTRACHEAL INTUBATION 2 0.0007
394 BRAIN OEDEMA 9 0.0007
395 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
396 OXYGEN SATURATION ABNORMAL 2 0.0007
397 SPEECH DISORDER DEVELOPMENTAL 2 0.0007
398 ENTEROCOLITIS 4 0.0007
399 ENCEPHALOPATHY 17 0.0007
400 HYPOTHERMIA 7 0.0007
401 URINE OUTPUT DECREASED 6 0.0007
402 GASTROINTESTINAL NECROSIS 2 0.0007
403 ACUTE ABDOMEN 1 0.0007
404 STRABISMUS 2 0.0007
405 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
406 METABOLIC ENCEPHALOPATHY 2 0.0007
407 CEREBROVASCULAR DISORDER 2 0.0007
408 INCONTINENCE 7 0.0007
409 SUDDEN DEATH 7 0.0007
410 ASTIGMATISM 1 0.0007
411 AGE-RELATED MACULAR DEGENERATION 1 0.0007
412 HAEMATOMA 17 0.0007
413 PNEUMONIA BACTERIAL 6 0.0007
414 SHOCK 15 0.0007
415 INTRACARDIAC THROMBUS 2 0.0007
416 INFUSION SITE EXTRAVASATION 4 0.0006
417 YELLOW SKIN 3 0.0006
418 LYMPHOPENIA 9 0.0006
419 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
420 HYPOXIA 22 0.0006
421 LYMPHOCYTE COUNT DECREASED 11 0.0006
422 AORTIC VALVE DISEASE 1 0.0006
423 SEPTIC SHOCK 27 0.0006
424 MITRAL VALVE INCOMPETENCE 7 0.0006
425 INCORRECT DOSAGE ADMINISTERED 3 0.0006
426 VENOOCCLUSIVE LIVER DISEASE 3 0.0006
427 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
428 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
429 CYTOMEGALOVIRUS INFECTION 10 0.0006
430 CARDIAC FAILURE ACUTE 4 0.0006
431 HYPERAMMONAEMIA 3 0.0006
432 PREGNANCY 12 0.0006
433 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
434 CORONARY ARTERY STENOSIS 3 0.0006
435 KLEBSIELLA INFECTION 3 0.0006
436 BK VIRUS INFECTION 2 0.0006
437 COLITIS ISCHAEMIC 4 0.0006
438 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
439 DIABETIC RETINOPATHY 2 0.0006
440 BLOOD AMYLASE INCREASED 1 0.0006
441 BRONCHOPNEUMONIA 2 0.0006
442 HYPERBILIRUBINAEMIA 6 0.0006
443 BLOOD CHLORIDE INCREASED 1 0.0006
444 ACUTE MYELOID LEUKAEMIA 9 0.0006
445 LUNG DISORDER 28 0.0006
446 MULTIPLE ORGAN DYSFUNCTION SYNDROME 16 0.0006
447 METABOLIC ACIDOSIS 18 0.0006
448 AORTIC VALVE STENOSIS 1 0.0006
449 CARDIOGENIC SHOCK 8 0.0006
450 PANCYTOPENIA 31 0.0006
451 LIVER TRANSPLANT 2 0.0005
452 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
453 DRUG LEVEL INCREASED 9 0.0005
454 IRON DEFICIENCY ANAEMIA 5 0.0005
455 URINARY RETENTION 18 0.0005
456 HYPERTENSIVE CRISIS 6 0.0005
457 MALNUTRITION 6 0.0005
458 ERYTHEMA MULTIFORME 5 0.0005
459 ABORTION INDUCED 5 0.0005
460 PEMPHIGOID 4 0.0005
461 TENDON PAIN 4 0.0005
462 BLOOD BICARBONATE DECREASED 1 0.0005
463 ACIDOSIS 4 0.0005
464 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
465 POST PROCEDURAL COMPLICATION 10 0.0005
466 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
467 SENSATION OF HEAVINESS 2 0.0005
468 CHOKING 10 0.0005
469 ABDOMINAL WALL HAEMATOMA 1 0.0005
470 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
471 HAEMORRHAGIC STROKE 4 0.0005
472 BLOOD PRESSURE DECREASED 34 0.0005
473 BICYTOPENIA 1 0.0005
474 VULVOVAGINAL MYCOTIC INFECTION 2 0.0005
475 HEPATITIS 13 0.0005
476 DRUG ERUPTION 9 0.0005
477 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
478 BACTERAEMIA 6 0.0005
479 EXPOSURE DURING PREGNANCY 31 0.0005
480 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
481 CANDIDIASIS 2 0.0005
482 CYSTITIS HAEMORRHAGIC 2 0.0005
483 FUNGAL SKIN INFECTION 2 0.0005
484 PERIPHERAL ISCHAEMIA 2 0.0005
485 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
486 HYPOTENSION 98 0.0005
487 CARDIOMEGALY 6 0.0005
488 LARYNGEAL OEDEMA 3 0.0005
489 VENTRICULAR TACHYCARDIA 8 0.0005
490 ILEUS 6 0.0005
491 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
492 PETECHIAE 5 0.0005
493 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
494 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
495 UTERINE HAEMORRHAGE 2 0.0005
496 ABSCESS LIMB 2 0.0005
497 CARDIAC FAILURE CHRONIC 2 0.0005
498 LUNG NEOPLASM 2 0.0005
499 PROCTALGIA 3 0.0005
500 DEMENTIA 13 0.0005
501 APHASIA 14 0.0005
502 LACTIC ACIDOSIS 15 0.0005
503 COMA 22 0.0005
504 PLEURAL EFFUSION 28 0.0005
505 ABDOMINAL ABSCESS 2 0.0005
506 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
507 CARDIAC ARREST 37 0.0004
508 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
509 METASTASES TO LYMPH NODES 3 0.0004
510 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
511 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
512 RENAL IMPAIRMENT 37 0.0004
513 MYOCARDITIS 5 0.0004
514 APHTHOUS STOMATITIS 1 0.0004
515 GRAND MAL CONVULSION 4 0.0004
516 NEPHROGENIC ANAEMIA 2 0.0004
517 FORMICATION 3 0.0004
518 BACTERIAL INFECTION 8 0.0004
519 APPLICATION SITE REACTION 3 0.0004
520 RESPIRATORY FAILURE 31 0.0004
521 RENAL FAILURE ACUTE 18 0.0004
522 SUBDURAL HAEMATOMA 6 0.0004
523 DRUG INTERACTION 66 0.0004
524 HYPERCHOLESTEROLAEMIA 4 0.0004
525 RASH VESICULAR 2 0.0004
526 MOUTH HAEMORRHAGE 3 0.0004
527 JAUNDICE 11 0.0004
528 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
529 ASCITES 12 0.0004
530 RENAL TUBULAR NECROSIS 4 0.0004
531 HEPATOMEGALY 4 0.0004
532 CYTOKINE RELEASE SYNDROME 8 0.0004
533 DYSLIPIDAEMIA 2 0.0004
534 ISCHAEMIC STROKE 7 0.0004
535 ABDOMINAL INFECTION 1 0.0004
536 ENDOCARDITIS 2 0.0004
537 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
538 PERICARDIAL EFFUSION 9 0.0004
539 HAEMOLYSIS 3 0.0004
540 ATRIOVENTRICULAR BLOCK 3 0.0004
541 VENTRICULAR EXTRASYSTOLES 4 0.0004
542 PULMONARY HAEMORRHAGE 3 0.0004
543 TORSADE DE POINTES 3 0.0004
544 BLOOD CREATINE PHOSPHOKINASE INCREASED 11 0.0004
545 LEUKOPENIA 19 0.0004
546 PULMONARY CONGESTION 5 0.0004
547 PNEUMOTHORAX 6 0.0004
548 AREFLEXIA 1 0.0004
549 MIOSIS 3 0.0004
550 CARDIAC FAILURE 30 0.0004
551 SENSORY LOSS 3 0.0004
552 HYPOCALCAEMIA 7 0.0004
553 BEHAVIOUR DISORDER 2 0.0004
554 BLOOD POTASSIUM INCREASED 6 0.0004
555 POST PROCEDURAL INFECTION 3 0.0004
556 ABDOMINAL RIGIDITY 1 0.0004
557 NORMAL NEWBORN 2 0.0004
558 BLOOD CREATININE INCREASED 24 0.0004
559 STAPHYLOCOCCAL INFECTION 12 0.0004
560 ANGIOEDEMA 16 0.0004
561 EMBOLISM 3 0.0004
562 LIVER DISORDER 16 0.0004
563 INTRACRANIAL PRESSURE INCREASED 2 0.0004
564 CONFUSIONAL STATE 58 0.0004
565 PULMONARY OEDEMA 16 0.0004
566 HAEMODIALYSIS 3 0.0004
567 ANGIOPATHY 2 0.0004
568 INFUSION SITE ERYTHEMA 3 0.0004
569 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
570 SKIN TOXICITY 2 0.0004
571 DISORIENTATION 14 0.0004
572 HEPATOCELLULAR INJURY 5 0.0004
573 DIALYSIS 5 0.0004
574 GENERALISED ERYTHEMA 2 0.0004
575 NEUROLOGICAL SYMPTOM 2 0.0003
576 PSEUDOMONAS INFECTION 3 0.0003
577 GASTRIC HAEMORRHAGE 4 0.0003
578 BLOOD MAGNESIUM DECREASED 3 0.0003
579 RENAL FAILURE 46 0.0003
580 BLOOD URIC ACID INCREASED 2 0.0003
581 BONE MARROW FAILURE 7 0.0003
582 STRESS CARDIOMYOPATHY 2 0.0003
583 POST PROCEDURAL HAEMORRHAGE 4 0.0003
584 PRODUCT LABEL CONFUSION 2 0.0003
585 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
586 HYPOVOLAEMIA 2 0.0003
587 HYPERTRIGLYCERIDAEMIA 2 0.0003
588 TUMOUR LYSIS SYNDROME 3 0.0003
589 SEPSIS 38 0.0003
590 LUNG INFILTRATION 3 0.0003
591 PLEURISY 2 0.0003
592 PRODUCT PRESCRIBING ERROR 8 0.0003
593 HAEMARTHROSIS 3 0.0003
594 HAEMORRHAGE INTRACRANIAL 5 0.0003
595 PROTHROMBIN TIME PROLONGED 2 0.0003
596 GOUT 6 0.0003
597 CYTOPENIA 4 0.0003
598 GENERALISED OEDEMA 4 0.0003
599 FAECES DISCOLOURED 7 0.0003
600 OLIGURIA 2 0.0003
601 BLOOD BLISTER 1 0.0003
602 MELAENA 7 0.0003
603 CYANOSIS 5 0.0003
604 INFUSION SITE SWELLING 2 0.0003
605 DELIRIUM 11 0.0003
606 THROMBOCYTOPENIA 35 0.0003
607 CARDIO-RESPIRATORY ARREST 13 0.0003
608 ATELECTASIS 3 0.0003
609 ANAPHYLACTIC SHOCK 8 0.0003
610 UNRESPONSIVE TO STIMULI 8 0.0003
611 HYPOGLYCAEMIA 15 0.0003
612 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
613 BRADYPHRENIA 2 0.0003
614 ASPERGILLUS INFECTION 2 0.0003
615 CORONAVIRUS INFECTION 2 0.0003
616 C-REACTIVE PROTEIN INCREASED 11 0.0003
617 NEUTROPENIA 41 0.0003
618 RESPIRATORY DISORDER 9 0.0003
619 HYPOTONIA 3 0.0003
620 HEPATIC FAILURE 9 0.0003
621 FEEDING DISORDER 6 0.0003
622 ANAEMIA 56 0.0003
623 PERITONITIS 6 0.0003
624 AORTIC STENOSIS 1 0.0003
625 SINUS TACHYCARDIA 4 0.0003
626 NEUTROPENIC SEPSIS 2 0.0003
627 PARALYSIS 4 0.0003
628 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
629 APPARENT DEATH 1 0.0003
630 HYPERTHYROIDISM 4 0.0003
631 PRODUCT DISPENSING ERROR 6 0.0003
632 GASTROENTERITIS 4 0.0003
633 ASPIRATION 3 0.0003
634 CARDIOMYOPATHY 4 0.0003
635 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
636 VENTRICULAR FIBRILLATION 3 0.0003
637 INTERSTITIAL LUNG DISEASE 13 0.0003
638 RASH PAPULAR 6 0.0003
639 HYPERTENSION 56 0.0003
640 AORTIC ANEURYSM 2 0.0003
641 RENAL FAILURE CHRONIC 2 0.0003
642 ACUTE RESPIRATORY FAILURE 5 0.0003
643 BLOOD BILIRUBIN INCREASED 7 0.0003
644 OEDEMA 14 0.0003
645 EYELID OEDEMA 3 0.0003
646 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
647 LUNG INFECTION 4 0.0003
648 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
649 PLATELET COUNT DECREASED 27 0.0003
650 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
651 CHOLECYSTITIS 3 0.0003
652 AZOTAEMIA 1 0.0003
653 WRIST FRACTURE 3 0.0003
654 DIABETIC KETOACIDOSIS 6 0.0002
655 TRANSPLANT REJECTION 2 0.0002
656 HYPERGLYCAEMIA 9 0.0002
657 LIVER INJURY 6 0.0002
658 ESCHERICHIA INFECTION 2 0.0002
659 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
660 SPINAL COMPRESSION FRACTURE 2 0.0002
661 VISUAL ACUITY REDUCED 8 0.0002
662 EOSINOPHIL COUNT INCREASED 2 0.0002
663 DERMATITIS 5 0.0002
664 PERICARDITIS 4 0.0002
665 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
666 MYDRIASIS 3 0.0002
667 HAEMOGLOBIN DECREASED 24 0.0002
668 BLOOD POTASSIUM DECREASED 7 0.0002
669 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
670 HEART RATE DECREASED 8 0.0002
671 SPINAL OSTEOARTHRITIS 2 0.0002
672 PANCREATITIS 12 0.0002
673 BLOOD CREATINE INCREASED 1 0.0002
674 MYOSITIS 2 0.0002
675 TACHYPNOEA 3 0.0002
676 HYPOTHYROIDISM 7 0.0002
677 INTENTIONAL OVERDOSE 14 0.0002
678 MOVEMENT DISORDER 7 0.0002
679 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
680 FLANK PAIN 2 0.0002
681 MUSCULAR WEAKNESS 24 0.0002
682 COLITIS 8 0.0002
683 BLOOD URINE PRESENT 4 0.0002
684 PROTEINURIA 4 0.0002
685 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
686 SINUS BRADYCARDIA 2 0.0002
687 LIVER FUNCTION TEST ABNORMAL 6 0.0002
688 PYREXIA 71 0.0002
689 PARKINSONISM 2 0.0002
690 HAEMORRHOIDS 4 0.0002
691 ANEURYSM 1 0.0002
692 DRUG LEVEL DECREASED 2 0.0002
693 OXYGEN SATURATION DECREASED 11 0.0002
694 DEVICE RELATED INFECTION 3 0.0002
695 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
696 CONVULSION 11 0.0002
697 NERVOUS SYSTEM DISORDER 6 0.0002
698 APLASTIC ANAEMIA 1 0.0002
699 DEAFNESS 5 0.0002
700 HALLUCINATION, VISUAL 4 0.0002
701 ANAL FISTULA 1 0.0002
702 ANAL FISSURE 1 0.0002
703 ANAL ABSCESS 1 0.0002
704 FALL 61 0.0002
705 OESOPHAGITIS 2 0.0002
706 ASTHENOPIA 1 0.0002
707 STOMATITIS 11 0.0002
708 OEDEMA PERIPHERAL 22 0.0002
709 FOOT DEFORMITY 2 0.0002
710 DIVERTICULITIS 5 0.0002
711 COAGULOPATHY 3 0.0002
712 FUNGAL INFECTION 6 0.0002
713 SYNCOPE 18 0.0002
714 TRANSAMINASES INCREASED 4 0.0002
715 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
716 GLOSSODYNIA 4 0.0002
717 BLOOD CALCIUM DECREASED 2 0.0002
718 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
719 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
720 SCAB 2 0.0002
721 HAEMATURIA 6 0.0002
722 HYPERSOMNIA 5 0.0002
723 LETHARGY 10 0.0002
724 LOSS OF CONSCIOUSNESS 22 0.0002
725 VASCULITIS 2 0.0002
726 SPLENOMEGALY 2 0.0002
727 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
728 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
729 COVID-19 PNEUMONIA 2 0.0002
730 SOMNOLENCE 34 0.0002
731 TACHYCARDIA 15 0.0002
732 THIRST 3 0.0002
733 POLYNEUROPATHY 2 0.0002
734 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
735 FEBRILE NEUTROPENIA 11 0.0002
736 LEUKOCYTOSIS 3 0.0002
737 OSTEOARTHRITIS 7 0.0002
738 NO THERAPEUTIC RESPONSE 2 0.0002
739 RESTLESSNESS 6 0.0002
740 BLOOD PRESSURE INCREASED 25 0.0002
741 SPINAL OPERATION 2 0.0002
742 HYPERCALCAEMIA 2 0.0002
743 BALANCE DISORDER 14 0.0002
744 MEDICATION ERROR 9 0.0002
745 EXTRAPYRAMIDAL DISORDER 4 0.0002
746 PHOTOPHOBIA 3 0.0002
747 DYSARTHRIA 6 0.0002
748 DRUG-INDUCED LIVER INJURY 5 0.0002
749 SLEEP APNOEA SYNDROME 3 0.0002
750 ANOREXIA 2 0.0002
751 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
752 DECREASED APPETITE 36 0.0002
753 ABDOMINAL PAIN 36 0.0002
754 PLATELET COUNT INCREASED 2 0.0002
755 CHOLELITHIASIS 5 0.0002
756 GASTRITIS 4 0.0002
757 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
758 HAEMATOCRIT DECREASED 3 0.0002
759 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
760 EYE HAEMORRHAGE 2 0.0001
761 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
762 VERTIGO 9 0.0001
763 DYSKINESIA 6 0.0001
764 PALLOR 4 0.0001
765 DRUG TOXICITY 2 0.0001
766 ABNORMAL LOSS OF WEIGHT 1 0.0001
767 GINGIVAL BLEEDING 2 0.0001
768 RASH ERYTHEMATOUS 7 0.0001
769 RIB FRACTURE 3 0.0001
770 PNEUMONIA 47 0.0001
771 MENTAL STATUS CHANGES 4 0.0001
772 PULMONARY HYPERTENSION 3 0.0001
773 AUTOIMMUNE HEPATITIS 1 0.0001
774 ATRIAL FIBRILLATION 14 0.0001
775 WOUND 4 0.0001
776 BLOOD TEST ABNORMAL 2 0.0001
777 CONSTIPATION 31 0.0001
778 RECTAL HAEMORRHAGE 6 0.0001
779 CELLULITIS 7 0.0001
780 MYELODYSPLASTIC SYNDROME 2 0.0001
781 INJECTION SITE HAEMATOMA 2 0.0001
782 AGITATION 10 0.0001
783 BLINDNESS TRANSIENT 1 0.0001
784 STEVENS-JOHNSON SYNDROME 3 0.0001
785 TOOTH DISORDER 3 0.0001
786 TINNITUS 6 0.0001
787 PHARYNGEAL OEDEMA 2 0.0001
788 TENDONITIS 2 0.0001
789 APNOEA 1 0.0001
790 ARRHYTHMIA 6 0.0001
791 BLOOD DISORDER 1 0.0001
792 BLISTER 7 0.0001
793 SENSORY DISTURBANCE 2 0.0001
794 HAEMORRHAGE 13 0.0001
795 URINARY TRACT INFECTION 21 0.0001
796 NEUTROPHIL COUNT DECREASED 5 0.0001
797 MANIA 2 0.0001
798 SEIZURE 14 0.0001
799 SKIN DISORDER 4 0.0001
800 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
801 FACE OEDEMA 2 0.0001
802 CHRONIC KIDNEY DISEASE 9 0.0001
803 HAEMATEMESIS 3 0.0001
804 HYPOPHAGIA 3 0.0001
805 ERECTILE DYSFUNCTION 3 0.0001
806 SKIN ULCER 3 0.0001
807 CONDITION AGGRAVATED 35 0.0001
808 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6 0.0001
809 NEUROTOXICITY 2 0.0001
810 BLOOD CALCIUM INCREASED 1 0.0001
811 METASTASES TO LIVER 2 0.0001
812 HEAD DISCOMFORT 2 0.0001
813 VOMITING 53 0.0001
814 ASTHENIA 42 0.0001
815 PNEUMONITIS 3 0.0001
816 BONE DISORDER 2 0.0001
817 END STAGE RENAL DISEASE 2 0.0001
818 HEPATIC STEATOSIS 2 0.0001
819 APPENDICITIS 1 0.0001
820 DIARRHOEA 68 0.0001
821 PULMONARY EMBOLISM 10 0.0001
822 DISEASE RECURRENCE 5 0.0001
823 PRODUCTIVE COUGH 5 0.0001
824 ANGINA PECTORIS 3 0.0001
825 OFF LABEL USE 90 0.0001
826 DYSSTASIA 3 0.0001
827 ORAL HERPES 2 0.0001
828 ACUTE MYOCARDIAL INFARCTION 3 0.0001
829 URINARY INCONTINENCE 3 0.0001
830 BLADDER DISORDER 1 0.0001
831 PRESCRIBED UNDERDOSE 2 0.0001
832 CARDIAC FAILURE CONGESTIVE 8 0.0001
833 DEHYDRATION 13 0.0001
834 CHEST PAIN 18 0.0001
835 ECZEMA 5 0.0001
836 PAIN IN EXTREMITY 28 0.0001
837 DYSPHAGIA 9 0.0001
838 BRONCHITIS 7 0.0001
839 CHILLS 11 0.0001
840 JOINT INJURY 2 0.0001
841 LIVER FUNCTION TEST INCREASED 2 0.0001
842 HALLUCINATION 7 0.0001
843 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
844 HAEMATOCHEZIA 5 0.0001
845 ANAPHYLACTIC REACTION 5 0.0001
846 HEPATOTOXICITY 2 0.0001
847 CHROMATURIA 2 0.0001
848 PRODUCT AVAILABILITY ISSUE 2 0.0001
849 RENAL DISORDER 4 0.0001
850 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
851 ACCIDENTAL OVERDOSE 3 0.0001
852 MEMORY IMPAIRMENT 11 0.0001
853 OVERDOSE 17 0.0001
854 DEEP VEIN THROMBOSIS 5 0.0001
855 RESPIRATORY TRACT INFECTION 2 0.0001
856 MUCOSAL INFLAMMATION 2 0.0001
857 SEDATION 2 0.0001
858 BEDRIDDEN 1 0.0001
859 ABNORMAL BEHAVIOUR 3 0.0001
860 ABORTION SPONTANEOUS 3 0.0001
861 THROMBOSIS 6 0.0001
862 FEAR 2 0.0001
863 BLOOD GLUCOSE INCREASED 14 0.0001
864 DISTURBANCE IN ATTENTION 4 0.0001
865 DRY MOUTH 6 0.0001
866 RASH PRURITIC 4 0.0001
867 LIMB INJURY 2 0.0001
868 HEPATIC ENZYME INCREASED 5 0.0001
869 ACUTE HEPATIC FAILURE 1 0.0001
870 ERYTHEMA 15 0.0001
871 MALAISE 32 0.0001
872 RESPIRATORY ARREST 2 0.0001
873 HAEMOPTYSIS 2 0.0001
874 PAIN IN JAW 2 0.0001
875 HYPERSENSITIVITY 13 0.0001
876 DYSPNOEA 39 0.0001
877 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
878 APATHY 1 0.0001
879 NASAL CONGESTION 4 0.0001
880 DISEASE PROGRESSION 8 0.0001
881 RENAL INJURY 2 0.0001
882 BLOOD COUNT ABNORMAL 1 0.0001
883 DIABETES MELLITUS 5 0.0001
884 GYNAECOMASTIA 2 0.0001
885 LIMB DISCOMFORT 2 0.0001
886 ANKLE FRACTURE 1 0.0001
887 FEMUR FRACTURE 2 0.0001
888 BLOOD CHOLESTEROL INCREASED 3 0.0001
889 COGNITIVE DISORDER 3 0.0001
890 GAIT DISTURBANCE 12 0.0001
891 ABSCESS 1 0.0001
892 INFECTION 9 0.0001
893 OSTEONECROSIS 2 0.0001
894 LIP SWELLING 2 0.0001
895 AGGRESSION 3 0.0001
896 PALPITATIONS 7 0.0001
897 RASH 26 0.0001
898 FLUID RETENTION 3 0.0001
899 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
900 INFLAMMATION 3 0.0001
901 WEIGHT INCREASED 13 0.0001
902 NEOPLASM PROGRESSION 2 0.0001
903 ABDOMINAL DISTENSION 6 0.0001
904 MYOCARDIAL INFARCTION 10 0.0001
905 SPEECH DISORDER 3 0.0001
906 PRURITUS 22 0.0001
907 RASH MACULAR 2 0.0001
908 INCORRECT DOSE ADMINISTERED 13 0.0001
909 INJURY 4 0.0001
910 VISUAL IMPAIRMENT 7 0.0001
911 BACK PAIN 13 0.0001
912 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
913 GASTROINTESTINAL DISORDER 5 0.0001
914 ARTHRALGIA 23 0.0001
915 HYPERHIDROSIS 7 0.0001
916 DYSURIA 2 0.0001
917 DIZZINESS 27 0.0001
918 EPISTAXIS 4 0.0001
919 PRODUCT USE ISSUE 10 0.0001
920 DYSPNOEA EXERTIONAL 2 0.0001
921 ASTHMA 6 0.0001
922 DEPRESSION 12 0.0001
923 CONTUSION 5 0.0001
924 NAUSEA 39 0.0000
925 TOXICITY TO VARIOUS AGENTS 8 0.0000
926 HEADACHE 29 0.0000
927 AMNESIA 3 0.0000
928 TREMOR 7 0.0000
929 OCULAR HYPERAEMIA 2 0.0000
930 NEUROPATHY PERIPHERAL 4 0.0000
931 CEREBROVASCULAR ACCIDENT 7 0.0000
932 ABASIA 1 0.0000
933 FATIGUE 31 0.0000
934 ABDOMINAL PAIN LOWER 1 0.0000
935 COUGH 11 0.0000
936 CHEST DISCOMFORT 4 0.0000
937 ANHEDONIA 1 0.0000
938 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
939 VISION BLURRED 5 0.0000
940 URTICARIA 6 0.0000
941 NECK PAIN 2 0.0000
942 SKIN EXFOLIATION 3 0.0000
943 HERPES ZOSTER 2 0.0000
944 PRODUCT SUBSTITUTION ISSUE 2 0.0000
945 INTENTIONAL PRODUCT MISUSE 3 0.0000
946 DYSPHONIA 2 0.0000
947 SURGERY 2 0.0000
948 WHEEZING 2 0.0000
949 THERAPEUTIC RESPONSE DECREASED 2 0.0000
950 CARDIAC DISORDER 3 0.0000
951 SWELLING 3 0.0000
952 ANXIETY 9 0.0000
953 MIGRAINE 3 0.0000
954 PAIN 19 0.0000
955 DYSPEPSIA 3 0.0000
956 INSOMNIA 8 0.0000
957 COVID-19 5 0.0000
958 SLEEP DISORDER 2 0.0000
959 MOBILITY DECREASED 2 0.0000
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
961 NO ADVERSE EVENT 5 0.0000
962 UNDERDOSE 2 0.0000
963 NASOPHARYNGITIS 5 0.0000
964 DYSGEUSIA 2 0.0000
965 UNEVALUABLE EVENT 2 0.0000
966 PARAESTHESIA 4 0.0000
967 WEIGHT DECREASED 7 0.0000
968 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
969 DRUG INEFFECTIVE 32 0.0000
970 ABDOMINAL DISCOMFORT 4 0.0000
971 MYALGIA 4 0.0000
972 MUSCULOSKELETAL STIFFNESS 2 0.0000
973 ADVERSE EVENT 2 0.0000
974 OROPHARYNGEAL PAIN 2 0.0000
975 HEART RATE INCREASED 2 0.0000
976 HYPOAESTHESIA 3 0.0000
977 FLUSHING 2 0.0000
978 SINUSITIS 2 0.0000
979 DEATH 16 0.0000
980 ARTHROPATHY 1 0.0000
981 RHEUMATOID ARTHRITIS 2 0.0000
982 FEELING ABNORMAL 4 0.0000
983 EMOTIONAL DISTRESS 2 0.0000
984 INJECTION SITE ERYTHEMA 2 0.0000
985 DRY SKIN 2 0.0000
986 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
987 PRODUCT QUALITY ISSUE 2 0.0000
988 PERIPHERAL SWELLING 2 0.0000
989 ARTHRITIS 1 0.0000
990 DRUG DOSE OMISSION 2 0.0000
991 ABDOMINAL PAIN UPPER 2 0.0000
992 ALOPECIA 1 0.0000